Publicacions en què col·labora amb MIGUEL QUIRÓS OLOZÁBAL (10)

2020

  1. Anti-diabetic and anti-parasitic properties of a family of luminescent zinc coordination compounds based on the 7-amino-5-methyl-1,2,4-triazolo[1,5-a]pyrimidine ligand

    Journal of Inorganic Biochemistry, Vol. 212

  2. Lanthanide(III) Based Complexes Containing 5,7-Dimethyl-1,2,4-triazolo[1,5-a]pyrimidine as Long-Lived Photoluminescent Antiparasitic Agents

    European Journal of Inorganic Chemistry, Vol. 2020, Núm. 3, pp. 308-317

2019

  1. High antiparasitic activity of silver complexes of 5,7-dimethyl-1,2,4-triazolo[1,5 a]pyrimidine

    Journal of Inorganic Biochemistry, Vol. 201

2014

  1. Triazolopyrimidine compounds containing first-row transition metals and their activity against the neglected infectious Chagas disease and leishmaniasis

    European Journal of Medicinal Chemistry, Vol. 85, pp. 526-534

2012

  1. Structural consequences of the introduction of 2,2′-bipyrimidine as auxiliary ligand in triazolopyrimidine-based transition metal complexes. in vitro antiparasitic activity

    Polyhedron, Vol. 33, Núm. 1, pp. 137-144

2011

  1. Bis(cyanato-κN)bis(5,7-dimethyl-1,2,4-triazolo[1,5-a] pyrimidine-κN3)zinc

    Acta Crystallographica Section E: Structure Reports Online, Vol. 67, Núm. 3

  2. New copper(II), nickel(II) and zinc(II) complexes with 1,2,4-triazolo[1,5- a]pyrimidines and the chelating ligand 1,3-propanediamine: An unexpected coordination behavior for the 7-amine-derivative

    Inorganica Chimica Acta, Vol. 378, Núm. 1, pp. 194-201

2010

  1. Influence of pseudohalide ligands on the structural versatility and properties of novel ternary metal complexes with 1,2,4-triazolo[1,5-a]pyrimidine

    CrystEngComm, Vol. 12, Núm. 10, pp. 3038-3045

2009

  1. A study of the second coordination sphere in 8-azaxanthinato salts of divalent metal aquacomplexes

    Inorganica Chimica Acta, Vol. 362, Núm. 5, pp. 1553-1558

  2. Versatile binding behaviour of 4,6-dimethyl-1,2,3-triazolo[4,5-d]- pyrimidin-5,7-dionato in the presence of bipyrimidine. Supramolecular H-bond architectures

    Dalton Transactions, pp. 10311-10317